Found 46 matching trials
Study of Trilaciclib and Lurbinectidin PHASE2 Lung cancer is by far the leading cause of cancer death among both men and ...
Show More Location
Dartmouth Hitchcock Medical Center
Learn More & Join Trial
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) PHASE1 This is a study to investigate the potential clinical benefit of trilacicli...
Show More Location
Genesis Cancer Center
Learn More & Join Trial
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib PHASE2 This study is a prospective, open label, randomized controlled clinical tri...
Show More Location
Fudan University Shanghai Cencer Center,
Learn More & Join Trial
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients PHASE2 This is a prospective, single-arm, multi-center, phase II clinical study to...
Show More Location
Department of Medical Oncology, Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): PHASE3 This was a randomized, double-blind, placebo-controlled, global, multicente...
Show More Location
AZ Oncology Associates - HOPE
Learn More & Join Trial
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer PHASE3 The goal of this clinical trial is to compare the efficacy and safety of tr...
Show More Location
Pharmacosmos Investigational Site
Learn More & Join Trial
Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma PHASE2 This prospective, single-arm, exploratory, phase II study was designed to e...
Show More Location
Multiple Locations
Learn More & Join Trial
Trilaciclib Combined With Immunochemotherapy for R/M HNSCC PHASE2 This study is a prospective, single-arm, phase II clinical trial involving ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis PHASE2 To observe the efficacy of Trilaciclib combined with lateral ventricular ch...
Show More Learn More & Join Trial
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab PHASE2 This is a Phase 2, multicenter, randomized, open-label study evaluating the...
Show More Location
Valkyrie Clinical Trial
Learn More & Join Trial